Appendix G
Mesasal | healthdirect
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Inflammatory bowel disease: clinical aspects and established and evolving therapies - The Lancet
Patient self-administered questionnaire | Download Scientific Diagram
PDF) A retrospective analysis of 20-year data of the surgical management of ulcerative colitis patients in Taiwan: A study of Taiwan Society of Inflammatory Bowel Disease
Canasa Rectal Advanced Patient Information - Drugs.com
Full article: Modern use of 5-aminosalicylic acid compounds for ulcerative colitis
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation | SpringerLink
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Current Oral 5-ASA formulations. | Download Table
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
INFORMATION TO USERS
What is Sfrowasa? - GoodRx
PDF) Update on the management of ulcerative colitis: Treatment and maintenance approaches focused on MMX® mesalamine
Patient self-administered questionnaire | Download Scientific Diagram
Mesasal | healthdirect
Safety Data Sheet - Version 5.0
Mesasal PI
Prolonged-Release Mesalazine | SpringerLink
PDF) The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro‐drugs used in the management of ulcerative colitis | William Sandborn - Academia.edu
Therapeutic Approaches to the Treatment of Ulcerative Colitis
